XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.22.1

SHARE-BASED COMPENSATION | 3 Months Ended
--- | ---
Mar. 31, 2022
Share-based Payment Arrangement [Abstract] |
SHARE-BASED COMPENSATION | SHARE-BASED COMPENSATIONIn April 2021, the Company’s shareholders approved an amended and restated 2010 Incentive Award Plan to provide for an increase in the number of shares of common stock reserved for issuance thereunder from 97,350,000 to 103,350,000. As of March 31, 2022, approximately 21.4 million shares were reserved for future issuance under the Company’s stock plans. A maximum of approximately 9.3 million of these shares can be awarded as restricted stock units (“RSUs”). Stock Options Information A summary of stock option activity under all stock plans for the three months ended March 31, 2022, is presented as follows (in millions, except per share amounts):
|  | Stock Options Outstanding
|  | Number Outstanding |  | Weighted-Average Exercise Price Per Share
Balance as of December 31, 2021 |  | 11.7 |  |  | $ | 125.07 |
Options granted |  | 0.5 |  |  | $ | 290.51 |
Options exercised |  | (0.4) |  |  | $ | 79.29 |
Options forfeited/expired |  | — |  |  | $ | 226.29 |
Balance as of March 31, 2022 |  | 11.8 |  |  | $ | 134.03 |
As of March 31, 2022, options to purchase an aggregate of 9.4 million shares of common stock were exercisable at a weighted average price of $104.08 per share. Restricted Stock Units Information A summary of RSUs activity under all stock plans for the three months ended March 31, 2022, is presented as follows (in millions, except per share amounts):
| Shares |  | Weighted-Average Grant-Date Fair Value
Unvested balance as of December 31, 2021 | 4.8 |  |  | $ | 207.37 |
RSUs granted | 1.5 |  |  | $ | 290.84 |
RSUs vested | (1.6) |  |  | $ | 186.75 |
RSUs forfeited | (0.1) |  |  | $ | 223.75 |
Unvested balance as of March 31, 2022 | 4.6 |  |  | $ | 241.94 |
Performance Share Units Beginning in 2022, in addition to RSUs and stock options, the Company granted performance share units (“PSUs”) to officers and other key employees subject to three-year cliff vesting and pre-established, quantitative goals. Whether any PSUs vest, and the amount that does vest, is tied to completion of service over three years and the achievement of three equally-weighted, quantitative goals that directly align with or help drive the Company’s strategy and long-term total shareholder return. The metrics are focused on relative total shareholder return (“TSR”), year-over-year procedure growth for 2023, and two-year compound annual procedure growth for 2024. TSR is considered a market condition, and the expense is determined at the grant date. This expense will not be adjusted even if the market condition is not met. The two procedure growth goals are considered performance conditions, and the expense is recorded over the vesting period based on the forecasted performance, which will be reassessed each reporting period based on the probability of achieving the two performance conditions. The number of shares earned at the end of the three-year period will vary, based on actual performance, from 0% to 125% of the target number of PSUs granted. PSUs are subject to forfeiture if employment terminates prior to the vesting date. PSUs are not considered issued or outstanding shares of the Company. The Company calculates the fair value for each component of the PSUs individually. The fair value for the component with the TSR metric was determined using Monte Carlo simulation. The fair value per share for the components with the procedure growth metrics is equal to the closing stock price on the grant date. As part of the Company’s annual grant in 2022, 0.1 million PSUs were granted at a weighted-average grant-date fair value of $299.32. Employee Stock Purchase Plan Under the Employee Stock Purchase Plan (“ESPP”), employees purchased approximately 0.2 million shares for $47.8 million and approximately 0.3 million shares for $41.4 million during the three months ended March 31, 2022, and 2021, respectively. Share-based Compensation Expense The following table summarizes share-based compensation expense for the three months ended March 31, 2022, and 2021 (in millions):
| Three Months Ended March 31, |  |
| 2022 |  | 2021 |  |  |  |
Cost of sales–products | $ | 18.7 |  |  | $ | 15.3 |  |  |  |  |
Cost of sales–services | 5.6 |  |  | 5.7 |  |  |  |  |
Total cost of sales | 24.3 |  |  | 21.0 |  |  |  |  |
Selling, general, and administrative | 60.3 |  |  | 53.1 |  |  |  |  |
Research and development | 36.8 |  |  | 30.1 |  |  |  |  |
Share-based compensation expense before income taxes | 121.4 |  |  | 104.2 |  |  |  |  |
Income tax benefit | 27.2 |  |  | 20.6 |  |  |  |  |
Share-based compensation expense after income taxes | $ | 94.2 |  |  | $ | 83.6 |  |  |  |  |
The Black-Scholes option pricing model is used to estimate the fair value of stock options granted under the Company’s share-based compensation plans and rights to acquire stock granted under the ESPP. The weighted-average estimated fair values of stock options and the rights to acquire stock under the ESPP, as well as the weighted-average assumptions used in calculating the fair values of stock options and the rights to acquire stock under the ESPP that were granted during the three months ended March 31, 2022, and 2021, were as follows:
| Three Months Ended March 31, |  |
| 2022 |  | 2021 |  |  |  |
Stock Options |  |  |  |  |  |  |
Risk-free interest rate | 1.6% |  | 0.7% |  |  |  |
Expected term (in years) | 3.5 |  | 4.3 |  |  |  |
Expected volatility | 35% |  | 34% |  |  |  |
Fair value at grant date | $80.80 |  | $70.33 |  |  |  |
ESPP |  |  |  |  |  |  |
Risk-free interest rate | 0.8% |  | 0.1% |  |  |  |
Expected term (in years) | 1.2 |  | 1.2 |  |  |  |
Expected volatility | 37% |  | 35% |  |  |  |
Fair value at grant date | $88.85 |  | $74.39 |  |  |  |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration